R97.21

The ICD-10-CM code for rising psa fol treatment for malignant neoplasm of prostate is R97.21. The full clinical description is "Rising PSA following treatment for malignant neoplasm of prostate". R97.21 is a billable/specific code that can be used on insurance claims and medical billing.

ICD-10-CM code R97.21 represents “Rising PSA following treatment for malignant neoplasm of prostate”. It is classified under Chapter 18: Symptoms, Signs and Abnormal Clinical and Laboratory Findings and is a billable/specific code that can be used on a claim.

Yes, R97.21 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.

R97.21 is in Chapter 18: Symptoms, Signs and Abnormal Clinical and Laboratory Findings (codes R00-R99).

R97.21 is linked to 1 UMLS Concept Unique Identifier: C4269227. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.

ICF (International Classification of Functioning, Disability and Health) codes describe how conditions like rising psa fol treatment for malignant neoplasm of prostate affect a person's functioning — body functions, activities, participation, and environmental factors. AutoICD provides ICF Core Sets for 12+ conditions and can map clinical text to ICF categories automatically. Browse the ICF directory to explore functioning codes.

There is no direct ICD-11 mapping available for R97.21 in the WHO crosswalk tables. This may mean the concept is classified differently in ICD-11. Use the ICD-10 to ICD-11 converter to search for related codes.